Media Healthcare Sector

Mind Medicine (MindMed)

Market Cap: US$539.5m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.

Xencor

Market Cap: US$538.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Eton Pharmaceuticals

Market Cap: US$531.3m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Enhabit

Market Cap: US$529.2m

Provides home health and hospice services in the United States.

LifeMD

Market Cap: US$524.0m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

Upstream Bio

Market Cap: US$517.5m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

OrthoPediatrics

Market Cap: US$515.9m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Axogen

Market Cap: US$514.6m

Develops and commercializes technologies for peripheral nerve regeneration and repair worldwide.

Bicara Therapeutics

Market Cap: US$505.6m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Owens & Minor

Market Cap: US$504.9m

Operates as a healthcare solutions company worldwide.

Community Health Systems

Market Cap: US$501.6m

Owns, leases, and operates general acute care hospitals in the United States.

Stoke Therapeutics

Market Cap: US$501.2m

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Talkspace

Market Cap: US$493.6m

Operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States.

Maze Therapeutics

Market Cap: US$490.5m

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.

Relay Therapeutics

Market Cap: US$488.6m

Operates as a clinical-stage precision medicines company.

Arvinas

Market Cap: US$488.3m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Kura Oncology

Market Cap: US$485.7m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Semler Scientific

Market Cap: US$483.9m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Auna

Market Cap: US$483.8m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Definitive Healthcare

Market Cap: US$480.0m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Botanix Pharmaceuticals

Market Cap: AU$745.1m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

Allergy Therapeutics

Market Cap: UK£355.1m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Capricor Therapeutics

Market Cap: US$479.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

SBC Medical Group Holdings

Market Cap: US$471.4m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Oxford Biomedica

Market Cap: UK£348.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Tyra Biosciences

Market Cap: US$469.0m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Verastem

Market Cap: US$468.2m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Theravance Biopharma

Market Cap: US$465.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

Castle Biosciences

Market Cap: US$464.8m

A molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma, and mental health conditions.

Zevra Therapeutics

Market Cap: US$462.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Cullinan Therapeutics

Market Cap: US$461.5m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

REGENXBIO

Market Cap: US$455.0m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Sana Biotechnology

Market Cap: US$451.1m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

PYC Therapeutics

Market Cap: AU$699.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.